Dopamine-dependent character of depressive-like behavior in WAG/Rij rats with genetic absence epilepsy

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 57, Issue 1, 2007, Pages 91-102

  Sarkisova, K Yu ^a   Kulikov, M A ^a   Mydzyanovskaya, I S ^a   Folomkina, A A ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Absence epilepsy; Agonist of dopamine D2 D3 receptors; Antagonist of dopamine D2 D3 receptors; Antidepressant therapy; Depressive like behavior; Imipramine; Parlodel (bromocriptine); Raclopride; WAG Rij rats; Wistar rats

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; IMIPRAMINE; RACLOPRIDE;

ABSENCE; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MALE; PHYSIOLOGY; RAT; RAT STRAIN;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DOPAMINE; DOPAMINE ANTAGONISTS; EPILEPSY, ABSENCE; IMIPRAMINE; MALE; RACLOPRIDE; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE D2;

EID: 34247252463     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Augustsson H., Meyerson B. Exploration and risk assessment: a comparative study of male house mice (Mus musculus) and two laboratory strains // Physiol. Behav. 2004. V. 81. No 4. P. 685-698.
8. 99mTc]TRODAT-1 SPEC imaging // Am. J. Psych. 2003. V. 160. No 10. P. 1836-1841.
9. Coenen A.M.L., van Luijtelaar E.L.J.M. Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats // Behav. Genet. 2003. V. 33. P. 635-655.
10. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety // Pharmacol. Biochem. Behav. 1989. V. 32. P. 777-785.
11. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs // Europ. J. Pharmacol. 2000. V. 405. P. 365-373.
12. Dziedzicka-Wasylewska M., Willner P., Papp M. Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment // Behav. Pharmacol. 1997. V. 8. No 6-7. P. 607-618.
13. Garcia-Cairasco N., Oliveira J.A.C., Wakamatsu H., Bueno S.T., Guimaraes F.S. Reduced exploratory activity of audiogenic seizure susceptible Wistar rats // Physiol. Behav. 1998. V. 64. No 5. P. 671-674.
14. Genn R.F., Higgs S., Cooper S.J. The effects of 7-OH-DPAT, quinpirole and raclopride on licking for sucrose solutions in the non-deprived rat // Behav. Pharmacol. 2003. V. 14. No 8. P. 609-617.
15. Kuznetsova G.D., Petrova E.V., Coenen A.M., van Luijtelaar E.L. Generalized absence epilepsy and catalepsy in rats // Physiol. Behav. 1996. V. 60. P. 1165-1169.
16. Lahmame A., del Arco C., Pazos A., Yritia M. Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? // Europ. J. Pharmacol. 1997. V. 337. P. 115-123.
17. Mathews K., Forbes N., Reid I.C. Sucrose consumption as a hedonic measure following chronic unpredictable mild stress // Physiol. Behav. 1995. V. 58. P. 241-248.
18. Midzianovskaya I.S., Kuznetsova G.D., Coenen A.M.L., Spiridonov A.M., van Luijtelaar E.L.J.M. Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats // Brain Res. 2001. V. 911. P. 62-70.
19. Midzianovskaya I.S., Shatskova A.B., Sarkisova K.Yu., van Luijtelaar G., Tuomisto L., Kuznetsova G.D. Convulsive and nonconvulsive epilepsy in rats: effects on behavioral response to novelty stress // Epilepsy Behav. 2005. V. 6. P. 543-551.
20. Muscat R., Sampson D., Willner P. Dopaminergic mechanism of imipramine action in an animal model of depression // Biol. Psychol. 1990. V. 28. P. 223-230.
21. Porsolt R.D., Lenegre A. Behavioral models of depression // Experimental Approaches to Anxiety and Depression/Eds Elliot J.M., Heal D.J., Marsden C.A. N.Y.: John Willey and Sons, 1992. P. 73-85.
22. Rogos R., Dziedzicka-Wasylewska M. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding - an autoradiographic analysis // Naunyn-Schmiedeberg's Arch. Pharmacol. 1999. V. 359. P. 178-186.
23. Rupniak N.M. Animal models of depression: challenges from a drug development perspective // Behav. Pharmacol. 2003. V. 14. No 5-6. P. 385-390.
24. Sarkisova K. Yu., Midzianovskaia I.S., Kulikov M.A. Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG/Rij rats with genetic absence epilepsy // Behav. Brain Res. 2003. V. 144. P. 211-226.
25. Sarkisova K.Yu., Kulikov M.A. Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures // Behav. Brain Res. 2006. V. 166. No 1. P. 9-18.
26. Schmitt U., Hiemke C. Strain differences in open-field and elevated plus-maze behavior of rats without and with pretest handling // Pharmacol. Biochem. Behav. 1998. V. 59. No 4. P. 807-811.
27. Walsh R.N., Cummins R.A. The open field test: a critical review // Psychol. Bull. 1976. V. 83. P. 482-504.
28. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression // Neurosci. Biobehav. Rev. 1992. V. 16. P. 525-534.
29. Willner P., Mitchell P.J. The validity of animal models of predisposition to depression // Behav. Pharmacol. 2002. V. 13. P. 169-188.
30. Willner P., Hale A.S., Argyropoulos S. Dopaminergic mechanism of antidepressant action in depressed patients // J. Affect. Disord. 2005. V. 86. No 1. P. 37-45.